VMAT monthly QA using two techniques: 2D ion chamber array with an isocentric gantry mount and an in vivo dosimetric device attached to gantry

2013 ◽  
Vol 13 (2) ◽  
pp. 240-246 ◽  
Author(s):  
P. Myers ◽  
S. Stathakis ◽  
C. Buckey ◽  
N. Papanikolaou

AbstractPurposeVarian RapidArc is a volumetric modulated arc therapy (VMAT) that obtains a conformal dose around the desired structure by employing variable gantry speed, dose rate and dynamic multileaf collimator (DMLC) speed as the gantry rotates about machine isocenter. This study is meant to build upon previous research by Ling et al. by completing the tests with an in vivo dosimetric device attached to the linac gantry and a 2D ionisation chamber array with an isocentric gantry mount.Materials and methodsTwo PTW detectors, seven29 array with gantry mount and DAVID, were attached to the linear accelerator gantry, allowing each device to remain perpendicular to the beam at all gantry angles. Three tests for RapidArc evaluation were performed on these devices including: dose rate and gantry speed variation, DMLC speed and dose rate variation and DMLC position accuracy. The reproducibility of the arc data was also reported.ResultsA picket fence plan varying dose rates (111 to 600 MU/minute) and gantry speeds (5·5 to 4·3°/second) was delivered consisting of seven sections of different combinations. These measurements were compared with static gantry, open field measurements and found to be within 2·39% for the DAVID device and 0·84% for the seven29. A four-section picket fence of varying DMLC speeds (0·46, 0·92, 1·84 and 2·76 cm/second) was similarly evaluated and found to be within 1·99% and 3·66% for the DAVID and seven29, respectively. For DMLC position accuracy, a picket fence arc plan was compared with a static picket fence and found to agree within 0.38% and 2.91%. Reproducibility for these three RapidArc plans was found to be within 0·30% and 2·70% for the DAVID and seven29.ConclusionThe DAVID and seven29 detectors were able to perform the RapidArc quality assurance tests efficiently and accurately and the results were reproducible. Periodic verification of DMLC movement, dose rate variation and gantry speed variation relating to RapidArc delivery can be completed in a timelier manner using this equipment.

2010 ◽  
Vol 38 (1) ◽  
pp. 264-271 ◽  
Author(s):  
Giorgia Nicolini ◽  
Alessandro Clivio ◽  
Luca Cozzi ◽  
Antonella Fogliata ◽  
Eugenio Vanetti

Biomedicines ◽  
2021 ◽  
Vol 9 (2) ◽  
pp. 181
Author(s):  
Loredana G. Marcu ◽  
Eva Bezak ◽  
Dylan D. Peukert ◽  
Puthenparampil Wilson

FLASH radiotherapy, or the administration of ultra-high dose rate radiotherapy, is a new radiation delivery method that aims to widen the therapeutic window in radiotherapy. Thus far, most in vitro and in vivo results show a real potential of FLASH to offer superior normal tissue sparing compared to conventionally delivered radiation. While there are several postulations behind the differential behaviour among normal and cancer cells under FLASH, the full spectra of radiobiological mechanisms are yet to be clarified. Currently the number of devices delivering FLASH dose rate is few and is mainly limited to experimental and modified linear accelerators. Nevertheless, FLASH research is increasing with new developments in all the main areas: radiobiology, technology and clinical research. This paper presents the current status of FLASH radiotherapy with the aforementioned aspects in mind, but also to highlight the existing challenges and future prospects to overcome them.


2021 ◽  
Vol 161 ◽  
pp. S1353-S1354
Author(s):  
M. Gutiérrez Ruiz ◽  
R. Astudillo Olalla ◽  
A.L. Rivero ◽  
P. érez ◽  
J.T. Anchuelo Latorre ◽  
...  

2020 ◽  
Vol 47 (5) ◽  
pp. 2242-2253 ◽  
Author(s):  
Samuel Ruiz‐Arrebola ◽  
Rosa Fabregat‐Borrás ◽  
Eduardo Rodríguez ◽  
Manuel Fernández‐Montes ◽  
Mercedes Pérez‐Macho ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document